Katherine Genis
Recent Quotes
"Phase 3 study data will support approval of MESO's MPC-150-IM."
—
Katherine Genis, Edison Investment Research
(3/24/16)
more >
"MSB continues to make good pipeline progress."
—
Katherine Genis, Edison Investment Research
(1/25/16)
more >
"The first patient was transplanted in STEM's Phase 2 dry AMD trial."
—
Katherine Genis, Edison Investment Research
(9/1/15)
more >
"MSB's pipeline continues to mature steadily."
—
Katherine Genis, Edison Investment Research
(8/19/15)
more >
"A decision in Japan on MSB's MSC-100-IV could be a significant catalyst."
—
Katherine Genis, Edison Investment Research
(7/23/15)
more >
"We believe STEM's shares offer considerable value."
—
Katherine Genis, Edison Investment Research
(6/8/15)
more >
"MSB's late-stage product pipeline is burgeoning."
—
Katherine Genis, Edison Investment Research
(3/30/15)
more >
"We estimate dry AMD could be a $2B opportunity for STEM."
—
Katherine Genis, Edison Investment Research
(1/7/15)
more >
